Peter Hohenstein

The paper develops four humanized DMD mouse models with specific human exon deletions to test exon skipping therapies for Duchenne muscular dystrophy.

The paper characterizes the SCON system in Cdh12 conditional knockout mice, revealing unintended splicing changes that affect mRNA expression.

The paper quantifies signalling effects of CTNNB1 mutations across cancer types and finds weakly activating mutations correlate with worse prognosis in hepatocellular carcinoma.

This study identifies genotype-phenotype correlations in Wilms tumor by analyzing genetically engineered mouse models with Wt1 loss or LIN28B overexpression, showing how these mutations induce cancer stem cell markers.

This study characterizes alternative splicing heterogeneity in high-risk Wilms tumors using RNAseq data, identifying splicing patterns linked to kidney development and EMT.

This paper introduces SCON, a short conditional intron for conditional knockout via one-step zygote injection, showing its function across vertebrate species.

The paper uses single-cell RNA sequencing to study mRNA splice isoform switching during mouse kidney development and identifies potential splicing regulators.